Listen to this page using ReadSpeaker
Posts tagged advanced cell technology

A “Bigger Boat” – The Role of Nanoparticle Treatments

NanoparticlesAfter a rigorous review process, the Foundation is funding eight new research projects for a wide range of conditions, including Leber congenital amaurosis (LCA), age-related macular degeneration (AMD) and retinitis pigmentosa (RP). You can read about these exciting projects in an article recently posted on the Foundation’s homepage.

Continue Reading…

Have I Got a Cure for You! Debunking an Alleged Treatment on the Internet

In the lab with beakerIt seems there is no dearth of fantastic cures being touted on the Internet and in email inboxes these days. Sort of reminds me of those old Western movies where the itinerant peddler sells the magic elixir that will cure any and all ailments you have. Continue Reading…

Japanese Group Plans Induced Pluripotent Stem Cell Clinical Trial

Rod cells derived from iPSC at the RIKEN labs.I just learned some promising news from the stem cell research front. RIKEN, an innovative research group in Japan, is hoping to launch a clinical trial of an age-related macular degeneration (AMD) treatment derived from induced pluripotent stem cells (iPSC). Based on my current knowledge, this would be the first-ever iPSC-based treatment for the retina to move into a human study.
Continue Reading…

Could Combining Future Treatments Be an Option?

Image of test tubesVISIONS 2012, the Foundation’s annual conference, taking place in Minneapolis, is only two weeks away. I am very much looking forward to all the science presentations, especially the closing session on Sunday, July 1 — not only because I will moderate, but because it will cover three promising clinical trials, as well the exciting prospect of someday combining therapies.
Continue Reading…

Rockin’ and Rollin’ for a Good Cause

Andy and Kim HilfigerWell, this is a first: the Foundation was mentioned, this week, in Rolling Stone magazine. Why? Because one of our fundraising dinner events, “Fashion Ball: Dining in the Dark,” brought together professionals from both the fashion and music industries at the The Plaza Hotel in New York City and raised more than $370,000.

Continue Reading…

ACT’s Stem Cell Clinical Trial Expanding to Bascom Palmer

Woman looking through microscopeI am pleased to report that Advanced Cell Technology (ACT) just received institutional review board approval to add Bascom Palmer Eye Institute in Miami, Florida, as a clinical trial site for its stem-cell-derived treatment for people with dry age-related macular degeneration (AMD). Bascom Palmer has been ranked by U.S. News & World Report as the best ophthalmology hospital in the U.S. for the last eight years, so they are no doubt a valuable addition to the study.
Continue Reading…